Sodium Valproate: Side Effects, Weight Gain, and Warnings (Part 2)

Medical Disclaimer: This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your psychiatrist or physician before making any changes to your medication regimen.

While Sodium Valproate is highly effective for Bipolar Disorder, it carries a complex and demanding safety profile. In Part 2, we detail the side effects—specifically focusing on weight gain—and the severe regulatory warnings associated with this medication.

---

Section 4: Side Effects & Safety Warnings

20. Common Side Effects (≥1 in 10 patients)

Most patients will experience side effects, particularly during the first few weeks of treatment.

• Weight Gain: Significant and rapid weight gain is reported by over 50% of patients. It is driven by increased appetite, hyperinsulinemia, and metabolic changes. Weight loss is exceedingly rare on this medication.
• Gastrointestinal Distress: Nausea, vomiting, and diarrhea are very common, especially with immediate-release tablets.
• Tremors: A fine, rapid shaking of the hands occurs in roughly 10-25% of patients (often treated with Propranolol).
• Drowsiness/Sedation: Feeling lethargic or experiencing a “foggy” brain.
• Alopecia (Hair Loss): Thinning of the hair or texture changes (becoming curly) is a known side effect.

21. Serious/Rare Side Effects Needing Emergency Care

• Hepatotoxicity: Severe liver damage. Symptoms include yellowing of the skin/eyes (jaundice), severe upper right abdominal pain, and dark urine.
• Pancreatitis: Life-threatening inflammation of the pancreas, indicated by sudden, agonizing stomach pain that radiates to the back, accompanied by severe vomiting.
• Thrombocytopenia: A dangerous drop in blood platelets, causing easy bruising or bleeding gums.
• Hyperammonemia: Elevated ammonia levels in the blood, leading to Valproate-Induced Encephalopathy (confusion, stupor).

22. Black Box Warnings (FDA/CDSCO)

Sodium Valproate carries the highest level of regulatory warnings:

• Teratogenicity: It causes severe birth defects (spina bifida) and long-term neurodevelopmental disorders (lower IQ) in infants exposed in utero.
• Hepatotoxicity: Fatal hepatic failure has occurred, usually within the first 6 months of treatment. Children under 2 years old are at the highest risk.
• Pancreatitis: Cases of life-threatening pancreatitis have been reported.

23. Signs of Toxicity or Overdose

Valproate has a narrow therapeutic index (toxicity occurs when serum levels exceed 125-150 mcg/mL).

• What to watch for: Extreme somnolence (inability to stay awake), heart block (slow/irregular heartbeat), deep coma, respiratory depression, and visual hallucinations.
• What to do immediately: Call emergency services. There is no specific antidote. Treatment involves supportive care and sometimes hemodialysis.

24. Withdrawal Symptoms & Risks

• Never Stop Abruptly: Stopping Sodium Valproate suddenly can trigger “status epilepticus” (continuous, life-threatening seizures), even in bipolar patients who do not have epilepsy. It can also cause a rapid, severe rebound manic episode. Tapering must be done under psychiatric supervision.

25. Allergy and Hypersensitivity Reactions

• DRESS Syndrome: Drug Reaction with Eosinophilia and Systemic Symptoms. A severe allergic reaction involving a skin rash, fever, swollen lymph nodes, and internal organ involvement. Requires immediate hospitalization.

26. Long-Term Side Effects

• Metabolic Syndrome: Long-term weight gain can lead to insulin resistance, elevated triglycerides, and Type-2 Diabetes.
• PCOS (Polycystic Ovary Syndrome): In women, long-term use is associated with the development of PCOS, menstrual irregularities, and elevated testosterone levels.
• Osteoporosis: Prolonged use can reduce bone mineral density, increasing the risk of fractures.

---

Next: Read Part 3: Drug Interactions, Contraindications, and Clinical Monitoring